709 filings
Page 14 of 36
424B3
duyg1xn
8 Apr 21
Prospectus supplement
4:35pm
8-K
vht2v9nx
8 Apr 21
Entry into a Material Definitive Agreement
4:20pm
424B3
d36kzy660j5g caohxie
11 Mar 21
Prospectus supplement
9:56pm
8-K
aqbq4px6i1019r
11 Mar 21
KemPharm Reports Fourth Quarter and Full-Year 2020 Financial Results
4:27pm
SC 13G/A
i4k32vivwq4u020143t
9 Mar 21
KEMPHARM / Mangless Daniel John ownership change
10:38am
424B3
u1r90djp38be pw
3 Mar 21
Prospectus supplement
8:00am
8-K
xf6mmvcr0
3 Mar 21
Regulation FD Disclosure
7:58am
EFFECT
ts2ettzqo9z
17 Feb 21
Notice of effectiveness
12:15am
SC 13G/A
ll3cyerhw0vfbgi
16 Feb 21
KEMPHARM / Delaware Street Capital Master Fund ownership change
7:01am
424B5
u6yhtfcw2
16 Feb 21
Prospectus supplement for primary offering
12:00am
SC 13G/A
nbcrnphqtw
12 Feb 21
KEMPHARM / Auctus Fund ownership change
2:23pm
SC 13G/A
6qygw60h
12 Feb 21
KEMPHARM / Mickle Travis C ownership change
12:00am
CORRESP
gs6t3lep
11 Feb 21
Correspondence with SEC
12:00am
UPLOAD
rd2bam
11 Feb 21
Letter from SEC
12:00am
424B3
4hhfl5
9 Feb 21
Prospectus supplement
5:06pm
8-K
fab4z qvvt43bpn
9 Feb 21
Termination of a Material Definitive Agreement
4:59pm
SC 13G
aonjpujp22zgqw
5 Feb 21
KEMPHARM / Auctus Fund ownership change
2:04pm
S-8
7mv19g61gmnm
4 Feb 21
Registration of securities for employees
5:27pm